Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
0.920
+0.030 (3.36%)
Dec 20, 2024, 4:00 PM EST - Market closed
Evaxion Biotech Revenue
Evaxion Biotech had revenue of $3.02M in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $3.30M. In the year 2023, Evaxion Biotech had annual revenue of $73.00K.
Revenue (ttm)
$3.30M
Revenue Growth
n/a
P/S Ratio
1.29
Revenue / Employee
$67,245
Employees
49
Market Cap
5.13M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SunLink Health Systems | 31.81M |
Sintx Technologies | 3.25M |
Predictive Oncology | 1.48M |
FOXO Technologies | 1.34M |
Syros Pharmaceuticals | 386.00K |
Sonnet BioTherapeutics Holdings | 18.63K |
EVAX News
- 5 weeks ago - Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1 - GlobeNewsWire
- 7 weeks ago - Evaxion announces business update and third quarter 2024 financial results - GlobeNewsWire
- 7 weeks ago - Evaxion to announce business update and third quarter 2024 financial results on October 31 - GlobeNewsWire
- 2 months ago - Strong validation of Evaxion's AI-Immunology™ platform in multiple clinical trials - GlobeNewsWire
- 2 months ago - Recent clinical data confirms significantly improved predictive power of Evaxion's AI-Immunology™ platform - GlobeNewsWire
- 3 months ago - Evaxion Biotech Partners With Merck To Expand Vaccine Development - Benzinga
- 3 months ago - Evaxion significantly expands vaccine development collaboration with MSD - GlobeNewsWire
- 3 months ago - Evaxion launches improved AI-Immunology™ platform for vaccine antigen prediction - GlobeNewsWire